echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Oncologist: In patients with advanced urothelial cancer treated with immune checkpoint inhibitors, body composition can be used as an independent predictor and prognostic marker

    The Oncologist: In patients with advanced urothelial cancer treated with immune checkpoint inhibitors, body composition can be used as an independent predictor and prognostic marker

    • Last Update: 2021-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A variety of immune checkpoint inhibitors (ICI) are approved for advanced urothelial cancer (UC)


    A variety of immune checkpoint inhibitors (ICI) are approved for advanced urothelial cancer (UC)


    The study retrospectively included 70 patients with advanced UC who received ICI treatment from 2015 to 2020


    The study retrospectively included 70 patients with advanced UC who received ICI treatment from 2015 to 2020


    The median age is 69.


    High visceral fat index (VFI) was associated with improved PFS (HR: 1.



     Prognostic factors

    Compared with patients with low-risk scores, OS (HR: 6.


    Compared with patients with low-risk scores, OS (HR: 6.



    OS



    Compared with patients with low bone density, OS (HR: 2.


    In summary, studies have shown that body composition can be used as a predictor of efficacy and prognostic markers for patients with advanced urothelial cancer treated with ICI


    Original source:

    D YLAN J.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.